Scotiabank Canada raises AbbVie target price to $320
智通财经2026/10/06 09:27Scotiabank of Canada raised its price target for AbbVie (ABBV.US) from $280 to $320.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UBS raises Brent crude price forecast for 2026-27
UBS: Due to continued supply disruptions in the Middle East, Brent crude oil price expectations for 2026-27 have been raised.
Spot platinum fell back to $1699.94 after reaching the $1700 mark.
Spot platinum has just broken through the $1,700.00/oz mark, now quoted at $1,699.94/oz, down 1.44% on the day; Nymex platinum futures main contract is currently quoted at $1,712.1/oz, down 0.67% on the day.
Citi raises AMD target price to $800
Citi has raised AMD (AMD.US) target price from $575 to $800.
Vido Energy Group CEO: Upcoming tenders will clarify the scale and location of oil releases in the coming weeks
Vitol Energy Group CEO: Upcoming tenders to be announced in the next few weeks will clarify how much oil will be released and the release locations.
Crypto prices
More
